NEW YORK (GenomeWeb) – The US Food and Drug Administration has issued an Emergency Use Authorization for Roche's LightMix Ebola Zaire rRT-PCR Test, a molecular diagnostic test for use by CLIA high-complexity laboratories or similarly qualified non-US labs.

The test is a real-time RT-PCR assay for the qualitative detection of Ebola virus RNA in human EDTA whole blood specimens from individuals with signs and symptoms of infection in conjunction with epidemiological risk factors.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.